1
Clinical Trials associated with TriPRIL CAR T CellsA Phase I Clinical Trial With TriPRIL CAR T Cells for the Treatment of Patients With Relapsed or Refractory Multiple Myeloma
This research study involves the study of TriPRIL CAR T Cells for treating people with relapsed or refractory multiple myeloma and to understand the side effects when treated with TriPRIL CAR T Cells.
This research study involves the study drugs:.
TriPRIL CAR T Cells
Fludarabine and Cyclophosphamide: Standardly used chemotherapy drugs as part of lymphodepleting process
100 Clinical Results associated with TriPRIL CAR T Cells
100 Translational Medicine associated with TriPRIL CAR T Cells
100 Patents (Medical) associated with TriPRIL CAR T Cells
100 Deals associated with TriPRIL CAR T Cells